Global Financial Private Client, LLC Amgen Inc Transaction History

Global Financial Private Client, LLC

$257 Billion
Q3 2024

A detailed history of Global Financial Private Client, LLC transactions in Amgen Inc stock. As of the latest transaction made, Global Financial Private Client, LLC holds 1,748 shares of AMGN stock, worth $514,838. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,748

Previous 1,628 7.37%

Holding current value

$514,838

Previous $509 Million 10.72%

% of portfolio

0.22%

Previous 0.21%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $37,125 - $40,485	120 Added 7.37%	1,748 $563 Million
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $10,510 - $12,772	40 Added 2.52%	1,628 $509 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $42,212 - $50,955	157 Added 10.97%	1,588 $449 Million
Q4 2023 May 15, 2024	BUY	$255.7 - $288.46 $4,858 - $5,480	19 Added 1.35%	1,431 $412 Million
Q3 2023 May 15, 2024	BUY	$218.65 - $271.46 $20,334 - $25,245	93 Added 7.05%	1,412 $376 Million
Q2 2023 May 15, 2024	SELL	$214.27 - $253.37 $1,071 - $1,266	-5 Reduced 0.38%	1,319 $297 Million
Q4 2022 May 15, 2024	BUY	$229.03 - $291.01 $17,864 - $22,698	78 Added 6.26%	1,324 $348 Million
Q3 2022 May 15, 2024	BUY	$224.46 - $253.15 $79,683 - $89,868	355 Added 39.84%	1,246 $287 Million
Q2 2022 May 15, 2024	BUY	$230.71 - $256.74 $48,449 - $53,915	210 Added 30.84%	891 $219 Million
Q3 2021 May 15, 2024	BUY	$212.27 - $248.7 $63,681 - $74,610	300 Added 78.74%	681 $146 Million
Q3 2020 May 15, 2024	SELL	$234.65 - $260.95 $10,089 - $11,220	-43 Reduced 10.14%	381 $97.3 Million
Q1 2020 May 15, 2024	BUY	$182.24 - $241.7 $5,649 - $7,492	31 Added 7.89%	424 $83.9 Million
Q4 2019 May 15, 2024	BUY	$189.21 - $243.2 $74,359 - $95,577	393 New	393 $94.7 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.

Account

Global Financial Private Client, LLC Amgen Inc Transaction History